Skip to main content

Patients with early stage breast cancer who have evaluation of the axilla

CBE ID
0222
1.4 Project
Cancer Endorsement Maintenance
Endorsed
Endorsement Status
Endorsement Removed
1.1 New or Maintenance
Maintenance
E&M Cycle
Fall 2012
Is Under Review
No
1.3 Measure Description

Percentage of women with Stage I-IIb breast cancer that received either axillary node dissection or Sentinel Lymph Node Biopsy (SLNB) at the time of surgery (lumpectomy or mastectomy)

    • 1.14 Numerator

      Number of women in the denominator that received either axillary node dissection or SLNB at the time of surgical resection of the primary tumor.

    • 1.15 Denominator

      Number of women with diagnosis of stage I-IIb breast cancer that received either lumpectomy or mastectomy

    • Most Recent Endorsement Activity
      Measure Retired and Endorsement Removed Cancer Endorsement Maintenance Project
      Initial Endorsement
      Last Updated
      Removal Date